Certainly does, cheers mate.I'm interested in the sector as long-term demand looks to be strong - especially for Zircon. ILU are spending some big $ for this exact reason.Ever taken a look at DRX?
RBL Recce Pharmaceuticals advances global reach with Indonesia’s approval for Phase 3 Diabetic Foot Infection Trial